Where does Xenon Pharmaceuticals's cash flow data come from?

Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$383.17M-10.8%	-$345.91M-12.9%	-$306.33M-10.1%	-$278.23M-10.7%	-$251.45M-7.3%
Depreciation and amortization	$2.47M-2.8%	$2.54M-2.1%	$2.6M-1.0%	$2.62M-0.3%	$2.63M+2.9%
Stock-based compensation	$58.43M+8.8%	$53.71M+1.0%	$53.19M+1.3%	$52.49M-1.9%	$53.49M+5.5%
Net cash from operating activities	-$306.36M-9.8%	-$279.12M-10.8%	-$252.02M-9.6%	-$229.94M-16.8%	-$196.85M-8.5%
Capital expenditures	$889K+11.3%	$799K-36.8%	$1.26M-19.6%	$1.57M-46.3%	$2.93M-4.7%
Net cash from investing activities	-$223.79M-203%	$218M-14.1%	$253.8M+17.6%	$215.77M-11.1%	$242.7M+47.1%
Net cash from financing activities	$958.98M+719%	$117.11M+646%	$15.71M+17.7%	$13.35M+0.5%	$13.28M+9.5%
Net increase (decrease) in cash	$429.21M+660%	$56.45M—	——	——	——
Free cash flow	-$307.25M-9.8%	-$279.92M-10.5%	-$253.29M-9.4%	-$231.51M-15.9%	-$199.78M-8.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Xenon Pharmaceuticals's cash flow data come from?: Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.